A mystery unraveled: Nontumorigenic pluripotent stem cells in human adult tissues

Expert Opinion on Biological Therapy

Volumn 14, Issue 7, 2014, Pages 917-929

  Simerman, Ariel A ^a   Perone, Marcelo J ^b   Gimeno, María L ^b   Dumesic, Daniel A ^a   Chazenbalk, Gregorio D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Instituto de Investigación en Biomedicina de Buenos Aires ^*  (Argentina)

Author keywords

Human pluripotent stem cells; Muse cells; Nontumorigenic; Regenerative medicine

Indexed keywords

ADIPOSE TISSUE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; GOLD STANDARD; HUMAN; IMMUNE SYSTEM; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; TISSUE REGENERATION; ADULT; CARCINOGENESIS; CELL PROLIFERATION; CYTOLOGY; TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84902134908     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2014.900538     Document Type: Review

References (100)

1. Haeckel E. Anthropogenie; oder entwickelungsgeschichte des menschen. In: Engelmann W, editor. 3rd edition. W. Engelmann, Leipzig; 1877. p. 144
2. Brunt KR, Weisel RD, Li RK. Stem cells and regenerative medicine - future perspectives. Can J Physiol Pharmacol 2012;90(3):327-35
3. Maehle AH. Ambiguous cells: the emergence of the stem cell concept in the nineteenth and twentieth centuries. Notes Rec R Soc Lond 2011;65(4):359-78
4. Bentzinger CF, Wang YX, von Maltzahn J, Rudnicki MA. The emerging biology of muscle stem cells: implications for cell-based therapies. Bioessays 2012;35(3):231-41
5. Majo F, Rochat A, Nicolas M, et al. Oligopotent stem cells are distributed throughout the mammalian ocular surface. Nature 2008;456(7219):250-4
6. Kao CY, Nomata K, Oakley CS, et al. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 1995;16(3):531-8
7. Trosko JE, Chang CC, Wilson MR, et al. Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods 2000;20(2):245-64
8. Tai MH, Chang CC, Kiupel M, et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26(2):495-502
9. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007;9(1):204
10. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8(9):726-36
11. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292(5819):154-6
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145-7
13. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76
14. Buta C, David R, Dressel R, et al. Reconsidering pluripotency tests: do we still need teratoma assays? Stem Cell Res 2013;11(1):552-62.
15. Seydoux G, Braun RE. Pathway to totipotency: lessons from germ cells. Cell 2006;127(5):891-904
16. Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. Adv Biochem Eng Biotechnol 2009;114:185-99
17. Kuroda Y, Kitada M, Wakao S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010;107(19):8639-43
18. Heneidi S, Simerman AA, Keller E, et al. Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One 2013;8(6):e64752
19. Ogura F, Wakao S, Kuroda Y, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with non-tumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev 2014; Epub ahead of print
20. Liu J, Yang Z, Qiu M, et al. Developmental potential of cloned goat embryos from an SSEA3(+) subpopulation of skin fibroblasts. Cell Reprogram 2013;15(2):159-65
21. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974;17(4):331-40
22. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4(5):267-74
23. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9(5):641-50
24. Ye ZQ, Burkholder JK, Qiu P, et al. Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth. Proc Natl Acad Sci USA 1994;91(25):12140-4
25. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211-28
26. Fang B, Song Y, Liao L, et al. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroidrefractory acute graft-versus-host disease. Transplant Proc 2007;39(10):3358-62
27. Kuroda Y, Dezawa M. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat Rec (Hoboken) 2013;297(1):98-110
28. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276(5309):71-4
29. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol 2012;5:19
30. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981;78(12):7634-8
31. Przyborski SA. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells 2005;23(9):1242-50
32. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1(1):55-70
33. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010;24(20):2239-63
34. Plath K, Lowry WE. Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011;12(4):253-65
35. Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol 2012;30(9):849-57
36. Geng YJ. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 2003;1010:687-97
37. Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem 2010;111(4):769-81
38. Okita K, Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci 2011;366(1575):2198-207
39. Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009;85(8):348-62
40. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4(6):472-6
41. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324(5928):797-801
42. Hanna J, Saha K, Pando B, et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462(7273):595-601
43. Kim J, Woo AJ, Chu J, et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010;143(2):313-24
44. Trosko JE. Commentary: "reprogramming or selecting adult stem cells?". Stem Cell Rev 2008;4(2):81-8
45. Trosko JE. Induction of iPS cells and of cancer stem cells: the stem cell or reprogramming hypothesis of cancer? Anat Rec (Hoboken) 2014;297(1):161-73.
46. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418(6893):41-9
47. Dimomeletis I, Deindl E, Zaruba M, et al. Assessment of human MAPCs for stem cell transplantation and cardiac regeneration after myocardial infarction in SCID mice. Exp Hematol 2010;38(11):1105-14
48. D'Ippolito G, Diabira S, Howard GA, et al. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004;117(Pt 14):2971-81
49. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 2009;17(6):939-46
50. Kucia M, Zuba-Surma EK, Wysoczynski M, et al. Adult marrowderived very small embryonic-like stem cells and tissue engineering. Expert Opin Biol Ther 2007;7(10):1499-514
51. Miyanishi M, Mori Y, Seita J, et al. Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Rep 2013;1(2):198-208.
52. Santourlidis S, Wernet P, Ghanjati F, et al. Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes. Stem Cell Res 2011;6(1):60-9
53. Obokata H, Wakayama T, Sasai Y, et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014;505(7485):641-7
54. Wesselschmidt RL. The teratoma assay: an in vivo assessment of pluripotency. Methods Mol Biol 2011;767:231-41
55. Wakao S, Kitada M, Kuroda Y, et al. Multilineage-differentiating stressenduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 2011;108(24):9875-80
56. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011;11(4):268-77
57. Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010;28(9):1568-70
58. Lee AS, Tang C, Rao MS, et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 2013;19(8):998-1004
59. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol 2012;22(9):474-82.
60. Reynolds PA, Sigaroudinia M, Zardo G, et al. Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem 2006;281(34):24790-802
61. Roy S, Gascard P, Dumont N, et al. Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc Natl Acad Sci USA 2012;110(12):4598-603
62. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 2000;9(4):489-502
63. Oh JS, Kim KN, An SS, et al. Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissuederived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model. Cell Transplant 2010;20(6):837-49
64. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111(17):2198-202
65. Dayem AA, Choi HY, Kim JH, Cho SG. Role of oxidative stress in stem, cancer, and cancer stem cells. Cancers (Basel) 2010;2(2):859-84
66. Kultz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 2005;67:225-57
67. Chacko SM, Ahmed S, Selvendiran K, et al. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 2010;299(6):C1562-70
68. Abdollahi H, Harris LJ, Zhang P, et al. The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res 2009;165(1):112-17
69. Li L, Bhatia R. Stem cell quiescence. Clin Cancer Res 2011;17(15):4936-41
70. Huang J, Zhang Z, Guo J, et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 2010;106(11):1753-62
71. Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2005;2(2):138-43
72. Guo G, Yan-Sanders Y, Lyn-Cook BD, et al. Manganese superoxide dismutasemediated gene expression in radiationinduced adaptive responses. Mol Cell Biol 2003;23(7):2362-78
73. Tsuchiyama K, Wakao S, Kuroda Y, et al. Functional melanocytes are readily reprogrammable from multilineagedifferentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. J Invest Dermatol 2013;133(10):2425-35
74. Chazenbalk G, Bertolotto C, Heneidi S, et al. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One 2011;6(3):e17834
75. Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15(8):921-9
76. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. Jama 2011;306(17):1891-901
77. Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103(12):4619-21
78. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105(4):1815-22
79. Ylostalo JH, Bartosh TJ, Coble K, Prockop DJ. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 2012;30(10):2283-96
80. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99(10):3838-43
81. Roddy GW, Oh JY, Lee RH, et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 2011;29(10):1572-9
82. Sato K, Ozaki K, Oh I, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109(1):228-34
83. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371(9624):1579-86
84. Comoli P, Ginevri F, Maccario R, et al. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 2008;23(4):1196-202
85. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007;149(2):353-63
86. Selmani Z, Naji A, Zidi I, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 +CD25highFOXP3+ regulatory T cells. Stem Cells 2008;26(1):212-22
87. Yachimovich-Cohen N, Even-Ram S, Shufaro Y, et al. Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism. J Immunol 2010;184(3):1300-8
88. Swijnenburg RJ, Schrepfer S, Govaert JA, et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci USA 2008;105(35):12991-6
89. De Filippo K, Dudeck A, Hasenberg M, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013;121(24):4930-7
90. Boscacci RT, Pfeiffer F, Gollmer K, et al. Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood 2010;116(6):915-25
91. del Castillo FJ, Cohen-Salmon M, Charollais A, et al. Consortin, a trans- Golgi network cargo receptor for the plasma membrane targeting and recycling of connexins. Hum Mol Genet 2010;19(2):262-75
92. O'Malley J, Skylaki S, Iwabuchi KA, et al. High-resolution analysis with novel cell-surface markers identifies routes to iPS cells. Nature 2013;499(7456):88-91
93. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11(3):298-300
94. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc 1972;20(4):145-7.
95. Hekimi S, Lapointe J, Wen Y. Taking a "good" look at free radicals in the aging process. Trends Cell Biol 2011;21(10):569-76
96. Wang CH, Wu SB, Wu YT, Wei YH. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) 2013;238(5):450-60
97. Kang KS, Trosko JE. Stem cells in toxicology: fundamental biology and practical considerations. Toxicol Sci 2011;120(Suppl 1):S269-89
98. Engle SJ, Puppala D. Integrating human pluripotent stem cells into drug development. Cell Stem Cell 2013;12(6):669-77
99. Yazawa M, Hsueh B, Jia X, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011;471(7337):230-4
100. Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000;407(6805):796-801